Financial statements Procareplus Pharma
Cash inflows of PROCAREPLUS PHARMA
|
Year
|
2019
|
2021
|
2022
|
|---|---|---|---|
| Net cash from operating expenses | -457 130,40 | -822 744,45 | -453 888,50 |
| Net cash flow from investing activities | -234 014,63 | -284 244,50 | 0,00 |
| Net cash flow from financial activities | 877 831,00 | 1 162 274,03 | 231 818,20 |
| Total net cash flow | 186 685,97 | 55 285,08 | -222 070,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.